Epithelial–mesenchymal plasticity in cancer: signaling pathways and therapeutic targets
MedComm · 2024-08 · 5 (8)
DOI: 10.1002/mco2.659 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, 2024-08. Verfasst von Xiangpeng Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Materia Medica Beijing University of Chinese Medicine Beijing China. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 263 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Currently, cancer is still a leading cause of human death globally. Tumor deterioration comprises multiple events including metastasis, therapeutic resistance and immune evasion, all of which are tightly related to the phenotypic plasticity especially epithelial–mesenchymal plasticity (EMP). Tumor cells with EMP are manifest in three states as epithelial–mesenchymal transition (EMT), partial EMT, and mesenchymal–epithelial transition, which orchestrate the phenotypic switch and heterogeneity of tumor cells via transcriptional regulation and a series of signaling pathways, including transforming growth factor‐β, Wnt/β‐catenin, and Notch. However, due to the complicated nature of EMP, the diverse process of EMP is still not fully understood. In this review, we systematically conclude the biological background, regulating mechanisms of EMP as well as the role of EMP in therapy response. We also summarize a range of small molecule inhibitors, immune‐related therapeutic approaches, and combination therapies that have been developed to target EMP for the outstanding role of EMP‐driven tumor deterioration. Additionally, we explore the potential technique for EMP‐based tumor mechanistic investigation and therapeutic research, which may burst vigorous prospects. Overall, we elucidate the multifaceted aspects of EMP in tumor progression and suggest a promising direction of cancer treatment based on targeting EMP.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Materia Medica Beijing University of Chinese Medicine Beijing China.
- School of Chinese Medicine Hong Kong Baptist University Kowloon Hong Kong China.
- Institute of Basic Research in Clinical Medicine China Academy of Chinese Medical Sciences Beijing China.
ORCID-Profile: Yuanyan Liu
Zitieren
APA
Wang, X., Xue, X., Pang, M., Yu, L., Qian, J., Li, X., Tian, M., Lyu, A., Lu, C., & Liu, Y. (2024). Epithelial–mesenchymal plasticity in cancer: signaling pathways and therapeutic targets. MedComm, 5(8). https://doi.org/10.1002/mco2.659
Vancouver
Wang X, Xue X, Pang M, Yu L, Qian J, Li X, et al. Epithelial–mesenchymal plasticity in cancer: signaling pathways and therapeutic targets. MedComm. 2024;5(8). doi:10.1002/mco2.659
BibTeX
@article{Wang2024,
author = {Wang, Xiangpeng and Xue, Xiaoxia and Pang, Mingshi and Yu, Liuchunyang and Qian, Jinxiu and Li, Xiaoyu and Tian, Meng and Lyu, Aiping and Lu, Cheng and Liu, Yuanyan},
title = {Epithelial–mesenchymal plasticity in cancer: signaling pathways and therapeutic targets},
journal = {MedComm},
year = {2024},
volume = {5},
number = {8},
doi = {10.1002/mco2.659}
}
EUVIMED